26 results
SC 13D/A
EX-3
10X Fund, L.P.
1 Dec 23
GALECTIN THERAPEUTICS / 10X Fund ownership change
4:38pm
10-K
2022 FY
EX-3.7
GALT
Galectin Therapeutics Inc
Annual report
30 Mar 23
7:52am
8-K
EX-3.1
GALT
Galectin Therapeutics Inc
19 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.3
GALT
Galectin Therapeutics Inc
19 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.2
GALT
Galectin Therapeutics Inc
19 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
kylfu9r
17 Feb 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.1
78cplls 9o5u4uz95
27 Sep 16
Galectin Therapeutics Announces Top-Line Data from Exploratory Phase 2a Pilot Trial (NASH-FX) with GR-MD-02 in NASH Patients with Advanced Fibrosis
12:00am
8-K
EX-3.1
9tg7yn6
30 May 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-3.2
y9i09m 0gn82u
30 May 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-3.1
ekfxh4453gzbas
23 Mar 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.3
nj953x2
2 Jun 11
Judge Paul Pressler Elected to the Board of Directors
12:00am
8-K
EX-3.2
xywt61 9fiy77
2 Jun 11
Judge Paul Pressler Elected to the Board of Directors
12:00am
8-K
EX-3.1
jhsus4puq ndyhfl
2 Jun 11
Judge Paul Pressler Elected to the Board of Directors
12:00am
8-K
EX-3.1
xhxog08mer f783oe
27 Jan 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
rz5t4ot2 a5c
6 Jan 11
Pro-pharmaceuticals Closes $2.1 Million Offering
12:00am
8-K
EX-3.1
7bhqcvmnc35q
17 Feb 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
deb9cy olb0
28 May 09
Departure of Directors or Certain Officers
12:00am